Market Overview:
The global respiratory tract infection treatment market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to factors such as rising incidence of respiratory tract infections, increasing awareness about respiratory tract infections, and technological advancements in the field of respiratory tract infection treatment. However, the high cost of advanced treatments and lack of reimbursement policies are restraining the growth of this market. The global respiratory tract infection treatment market is segmented on the basis of type, application, and region. On the basis of type, it is segmented into antibiotics, NSAIDS (non-steroidal anti-inflammatory drugs), cough suppressant, nose decongestant, and others. On the basis on application it is segmented into hospitals and clinics. Geographically it is divided into North America (U.S., Canada), Latin America (Mexico Brazil), Europe (Germany U.K., France Italy Spain), Asia Pacific (China Japan India South Korea Australia New Zealand) Middle East & Africa(South Africa Saudi Arabia UAE).
Product Definition:
Respiratory tract infection treatment is the use of medications or other therapies to cure or improve a respiratory tract infection. Respiratory tract infections can be caused by viruses, bacteria, or fungi and can affect the nose, throat, lungs, and airways. Treatment depends on the cause of the infection and may include antibiotics for bacterial infections, antiviral medications for viral infections, or antifungal medications for fungal infections. Treatment may also include over-the-counter pain relievers and fever reducers such as ibuprofen (Advil) or acetaminophen (Tylenol), rest and plenty of fluids to help relieve symptoms.
Antibiotics:
Antibiotics Market By Product (Penicillin, Cephalosporin, Fluoroquinolones), By Application (Respiratory Tract Infection Treatment) And Segment Forecasts To 2020 -> Growing prevalence of respiratory tract infections is expected to drive antibiotics market growth over the forecast period. According to a CDC study in 2009, about 2 million people in the U.S alone develop antibiotic-resistant bacteria annually which leads to more than 90% deaths worldwide.
NSAIDS:
Nonsteroidal Anti-inflammatory Drugs (NSAIDs) are used to reduce the inflammation and pain caused by a variety of conditions. Some of these drugs belong to the group of drugs known as cyclooxygenase-2 inhibitors, which were developed to treat arthritis and related diseases.
Application Insights:
Based on the application, the global respiratory tract infection treatment market is segmented into hospital and clinic. The hospital segment dominated the overall market in terms of revenue in 2017 due to a high prevalence of chronic diseases, especially lung disorders that require long-term medical management. In addition, an increase in healthcare expenditure globally has led to an increase in demand for advanced respiratory tract infection treatments at hospitals.
The Clinic segment is expected to grow significantly over the forecast period owing to increasing awareness about effective cough suppression methods among patients as well as their families. This will help reduce coughs and other upper respiratory symptoms associated with RTIs during colds and flu infections at home or elsewhere outside hospitals or clinics.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the high prevalence of respiratory tract infections, increasing geriatric population, and rising healthcare expenditure. According to a study published by Centers for Disease Control & Prevention (CDC) in 2016, around 13.6 million people died due to respiratory diseases in the U.S., accounting 49% of all deaths caused by non-communicable diseases.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to improving economic conditions and growing target population base especially in India and China as a result of increased immigration from developed countries such as Australia & New Zealand, etc.). In addition, favorable government initiatives are anticipated boost regional growth during future years as well as contribute significantly towards revenue generation during 2018-2030 periods respectively).
Growth Factors:
- Increasing incidence of respiratory tract infections (RTIs) due to changing lifestyle and environmental factors
- Growing awareness about the benefits of early diagnosis and treatment of RTIs
- Rising demand for point-of-care diagnostics for RTIs
- increasing number of product launches and approvals by regulatory authorities
- growing investments in research and development (R&D) activities for respiratory tract infection treatment
Scope Of The Report
Report Attributes
Report Details
Report Title
Respiratory Tract Infection Treatment Market Research Report
By Type
Antibiotics, NSAIDS, Cough Suppressant, Nose Decongestant, Others
By Application
Hospital, Clinic
By Companies
Abbott, AstraZeneca, Abbvie, Boehringer Ingelheim, Cipla Pharmaceutical, GlaxoSmithkline, Pfizer, Merck, Novartis, Roche, Sanofi, Teva
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
136
Number of Tables & Figures
96
Customization Available
Yes, the report can be customized as per your need.
Global Respiratory Tract Infection Treatment Market Report Segments:
The global Respiratory Tract Infection Treatment market is segmented on the basis of:
Types
Antibiotics, NSAIDS, Cough Suppressant, Nose Decongestant, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott
- AstraZeneca
- Abbvie
- Boehringer Ingelheim
- Cipla Pharmaceutical
- GlaxoSmithkline
- Pfizer
- Merck
- Novartis
- Roche
- Sanofi
- Teva
Highlights of The Respiratory Tract Infection Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibiotics
- NSAIDS
- Cough Suppressant
- Nose Decongestant
- Others
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Respiratory Tract Infection Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Respiratory tract infection treatment typically includes antibiotics to clear the infection and pain relief. In some cases, a breathing tube may be needed to help the person breathe.
Some of the key players operating in the respiratory tract infection treatment market are Abbott, AstraZeneca, Abbvie, Boehringer Ingelheim, Cipla Pharmaceutical, GlaxoSmithkline, Pfizer, Merck, Novartis, Roche, Sanofi, Teva.
The respiratory tract infection treatment market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Respiratory Tract Infection Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Respiratory Tract Infection Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Respiratory Tract Infection Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Respiratory Tract Infection Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Respiratory Tract Infection Treatment Market Size & Forecast, 2018-2028
4.5.1 Respiratory Tract Infection Treatment Market Size and Y-o-Y Growth
4.5.2 Respiratory Tract Infection Treatment Market Absolute $ Opportunity
Chapter 5 Global Respiratory Tract Infection Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Respiratory Tract Infection Treatment Market Size Forecast by Type
5.2.1 Antibiotics
5.2.2 NSAIDS
5.2.3 Cough Suppressant
5.2.4 Nose Decongestant
5.2.5 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Respiratory Tract Infection Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Respiratory Tract Infection Treatment Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Respiratory Tract Infection Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Respiratory Tract Infection Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Respiratory Tract Infection Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Respiratory Tract Infection Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Respiratory Tract Infection Treatment Market Size Forecast by Type
9.6.1 Antibiotics
9.6.2 NSAIDS
9.6.3 Cough Suppressant
9.6.4 Nose Decongestant
9.6.5 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Respiratory Tract Infection Treatment Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Respiratory Tract Infection Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Respiratory Tract Infection Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Respiratory Tract Infection Treatment Market Size Forecast by Type
10.6.1 Antibiotics
10.6.2 NSAIDS
10.6.3 Cough Suppressant
10.6.4 Nose Decongestant
10.6.5 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Respiratory Tract Infection Treatment Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Respiratory Tract Infection Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Respiratory Tract Infection Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Respiratory Tract Infection Treatment Market Size Forecast by Type
11.6.1 Antibiotics
11.6.2 NSAIDS
11.6.3 Cough Suppressant
11.6.4 Nose Decongestant
11.6.5 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Respiratory Tract Infection Treatment Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Respiratory Tract Infection Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Respiratory Tract Infection Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Respiratory Tract Infection Treatment Market Size Forecast by Type
12.6.1 Antibiotics
12.6.2 NSAIDS
12.6.3 Cough Suppressant
12.6.4 Nose Decongestant
12.6.5 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Respiratory Tract Infection Treatment Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Respiratory Tract Infection Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Respiratory Tract Infection Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Respiratory Tract Infection Treatment Market Size Forecast by Type
13.6.1 Antibiotics
13.6.2 NSAIDS
13.6.3 Cough Suppressant
13.6.4 Nose Decongestant
13.6.5 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Respiratory Tract Infection Treatment Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Respiratory Tract Infection Treatment Market: Competitive Dashboard
14.2 Global Respiratory Tract Infection Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott
14.3.2 AstraZeneca
14.3.3 Abbvie
14.3.4 Boehringer Ingelheim
14.3.5 Cipla Pharmaceutical
14.3.6 GlaxoSmithkline
14.3.7 Pfizer
14.3.8 Merck
14.3.9 Novartis
14.3.10 Roche
14.3.11 Sanofi
14.3.12 Teva
